Prevention of osteoporosis in women treated for hereditary breast and ovarian carcinoma: a need that is overlooked.
Lappe
J M
JM
Creighton University Schools of Nursing and Medicine, Creighton Osteoporosis Research Center, Omaha, Nebraska 68137, USA.
Tinley
S T
ST
D000328:Adult; D019386:Alendronate / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002116:Calcitonin / Q000627:therapeutic use; D004032:Diet; D004164:Diphosphonates / Q000627:therapeutic use; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D008019:Life Style; D009386:Neoplastic Syndromes, Hereditary / Q000188:drug therapy*; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D004164:Diphosphonates; D002116:Calcitonin; D019386:Alendronate